Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Denise Crute

Neurological Surgery Rockford, IL Medical Doctor

NPI 1346272747 CMS profile 714983

5666 E State St, Rockford, IL 61108

Open in the dashboard

General payments

$1,410

32 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Denise Crute of Rockford, IL is reported in the CMS Open Payments database as having received $1,410 across 32 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 37th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $75 3
2024 General $56 3
2023 General $60 3
2022 General $62 3
2021 General $19 1
2020 General $74 4
2019 General $1,064 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Denise Crute
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Denise Crute were reported at $75. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Denise Crute Neurological Surgery median Middle half National median
2019 $1,064 $582 $138–$3,006 $163
2020 $74 $294 $76–$2,174 $114
2021 $19 $387 $105–$2,432 $132
2022 $62 $542 $139–$2,989 $149
2023 $60 $534 $145–$2,697 $160
2024 $56 $574 $155–$3,046 $164
2025 $75 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,000 11 payments
  2. Avanos Medical $231 11 payments
  3. Orthogenrx Inc. $128 7 payments
  4. Fidia Pharma USA Inc. $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $740 7 payments
  2. Food and Beverage $670 25 payments
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER $870 7 payments
  2. GENVISC 850 SODIUM HYALURONATE Pain Management $209 10 payments
  3. GenVisc 850 $110 6 payments
  4. GENERAL PAIN MANAGEMENT $99 2 payments
  5. HYMOVIS $50 3 payments
  6. PRECISION $32 2 payments
  7. TRIVISC SODIUM HYALURONATE Pain Management $22 1 payment
  8. TRILURON $22 1 payment
  9. TriVisc sodium hyaluronate Osteoarthritis $19 1 payment
  10. GenVisc 850 sodium hyaluronate Osteoarthritis $19 1 payment
  11. Other $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$142,628

Of which drugs: $19,570

Medicare patients

229

Average age 74

Services billed

7,332

125 women, 104 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 73%
Diabetes 31%
Chronic kidney disease 24%
Depression 24%
Ischemic heart disease 21%
Heart failure 19%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg J7320 Office 46 4,577 $19,404
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 19 287 $78
Injection, ketorolac tromethamine, per 15 mg J1885 Office 30 85 $47
Injection, lidocaine hcl for intravenous infusion, 10 mg J2001 Office 18 41 $1

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

32 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record